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Abstract: Healthcare-associated infections (HCAIs) are a major source of morbidity and 
mortality and are the second most prevalent cause of death. Furthermore, it has been reported 
that for every one-hundred patients admitted to hospital, seven patients in high-income 
economies and ten in emerging and low-income economies acquire at least one type of 
HCAI. Currently, almost all pathogenic microorganisms have developed antimicrobial resis-
tance, and few new antimicrobials are being developed and brought to market. The literature 
search for this narrative review was performed by searching bibliographic databases (includ-
ing Google Scholar and PubMed) using the search terms: “Strategies,” “Prevention,” and 
“Healthcare-Associated Infections,” followed by snowballing references cited by critical 
articles. We found that although hand hygiene is a centuries-old concept, it is still the 
primary strategy used around the world to prevent HCAIs. It forms one of a bundle of 
approaches used to clean and maintain a safe hospital environment and to stop the transmis-
sion of contagious and infectious microorganisms, including multidrug-resistant microbes. 
Finally, antibiotic stewardship also has a crucial role in reducing the impact of HCAIs 
through conserving currently available antimicrobials. 
Keywords: prevention, hand hygiene, environmental hygiene, surveillance, antibiotic 
stewardship
Introduction
Infectious and contagious diseases are of global concern and are the second most 
common cause of death in flora and fauna.1 Communicable infectious diseases have 
threatened and challenged humans throughout history, where observers have 
recorded the advent of epidemics from epizootic diseases. Before communicable 
diseases were identified, infections were often attributed to various conditions: 
asters, environmental changes, acts of God, or spiritual reasons.2–4 The notions of 
transmissible and spreadable diseases emerged first, and those of contagious and 
infectious diseases emerged much later.5 In Europe between the 5th and the 15th 
centuries, contagious diseases had a substantial negative impact on public health.5 
From 1346–1353, plagues alone killed about 75 to 200 million of the European 
population, including the Bubonic plague known as the “Black Death.”6–9 Many 
European cities and towns were deserted as most of their communities died from 
the plague and other infectious diseases, with, for example, 300–400,000 people in 
Britain dying from the plague in one single outbreak in 1471.10–13 Regular, but less 
severe, plague epidemics continued until 1650.6 Before the discovery of antibiotics, 
average life expectancy was below 50 even for the people in high-income nations 
because of infectious diseases.14 The dramatic rise in life expectancy in the 20th 
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Century is primarily because of public health measures 
such as sanitation and the control of these diseases by 
antibiotics.14 Although it was once thought that infectious 
diseases could be totally controlled, they are still 
a substantial public health problem around the world and, 
because they remain the primary cause of death and infir-
mity, the costs of treating them are both high and 
increasing.15–21 At least 30 novel contagious and commu-
nicable diseases have appeared in the last 35 years, the 
majority of which are of zoonotic origin.22 Over recent 
years, the socioeconomic, environmental, and ecological 
impact of infectious diseases has increasingly affected the 
huge mobile global population, which is encountering both 
new infections (such as COVID-19) and battling the 
worldwide epidemic of multidrug-resistant existing infec-
tious diseases.23–33 Currently, almost all pathogenic micro-
organisms have developed some antimicrobial resistance, 
and few new antimicrobials are being developed and 
brought to market.
Healthcare-associated infections (HCAIs) are a major 
source of morbidity and mortality and are the second most 
prevalent cause of death globally.34–40 The World Health 
Organization (WHO) and other researchers report that 7% 
of patients in high-income economies and 10% in emer-
ging and developing economies acquire at least one type 
of HCAIs, and of these patients, 10% die.34–38 For exam-
ple, in the US, approximately 1.7 million individuals 
develop HCAIs annually (a prevalence rate of 4.5%), 
causing the death of 90,000–99,000 people.37,38 Another 
study found that 2,609,911 new cases of HCAIs were 
identified every year in the European Economic Area, 
causing 2,506,091 DALYs (Disability-Adjusted Life 
Years) per annum, corresponding to 501 DALYs per 
100,000 of the population.36–38 The prevalence rate of 
HCAIs in Lower- and Middle-Income Counties (LMICs) 
has been reported as between 5.7–19.1%.38 However, data 
on HCAIs is patchy, particularly from LMICs because of 
more inadequate infrastructures (such as data record- 
keeping) and lack of resources.38,41,42 The WHO con-
ducted a multicenter study estimating HCAIs in Intensive 
Care Units (ICU), finding that 51% of patients admitted to 
ICUs developed HCAIs, which prolonged their hospital 
stay and increased the risk of further infections and other 
morbidities.43 Infectious diseases cause 15 million deaths 
per year, of which 95% occur in the emerging economic 
nations, and these deaths are principally because of acute 
respiratory infections, diarrheal diseases, measles, AIDS, 
malaria, and tuberculosis.1 Furthermore, it has been 
estimated that globally more than 1.4 million patients 
have HCAIs at any one time in both advanced and emer-
gent countries, causing a substantial financial burden at an 
individual, community, and public levels.44 A considerable 
proportion of HCAIs are, however, preventable through 
proper infection prevention and control (IPC) policy and 
planning.38 This review presents current updates regarding 
global strategies to prevent healthcare-associated 
infections.
Materials and Methods
The literature search for this narrative review was per-
formed by searching bibliographic databases (including 
Google Scholar, and PubMed) (using free downloads as 
the research did not have financial support) provided by 
the Universiti Pertahanan Nasional Malaysia [(UPNM) the 
National Defence University of Malaysia], Kuala Lumpur, 
Malaysia and the University of the West Indies, 
St. Augustine, Trinidad, and Tobago. The search terms 
used were: “Strategies,” “Prevention,” “Hand Hygiene,” 
“Environmental Hygiene,” “Surveillance,” “Antibiotic 
Stewardship,” “Hospital Infections,” and “Healthcare- 
Associated Infections” followed by snowballing references 
cited by critical articles. All types of peer-reviewed articles 
published in English were included. Articles for which the 
full text was not available and those not written in English 
were excluded. From the articles retrieved in the first 
round of search, additional references were identified by 
a manual search among the cited references. As this is 
a narrative (not a systematic) review, whilst we have 
included principally recent papers, those with historical 
relevance (which are older papers) to the narrative have 
also been included.
Strategies to Prevent 
Healthcare-Associated Infections
HCAIs (their prevention and control) are a significant 
global public health burden about which concerns have 
been raised from all healthcare stakeholders, including 
health professionals, patients, and the public.45–48 Their 
impact has dramatically increased because of the advent 
of multidrug-resistant pathogenic microorganisms.49–51 
Currently, almost all available antimicrobials are 
resistant52,53 and very few antimicrobials are in the pro-
cess of being developed for widespread use.54–56 Amongst 
these pathogens, Klebsiella pneumoniae, which is the most 
common resistant pathogen, especially in ICU settings, is 
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a significant concern.57,58 The prevention and control of 
HCAIs is therefore very complicated, and a multi- 
dimensional approach and strategies are required to 
address this significant public health concern.36,50,59–63
In the following sections, we discuss the primary ways 
of addressing the impact of HCAIs as determined in the 
papers identified in the search and published in well- 
regarded journals36,45–200 These are the main issues iden-
tified in these papers, noting that (depending on the focus 
of the research and findings) some articles report on 
a single issue, whereas others report on a number.
● Hand hygiene
● Maintaining a safe, clean, hygienic hospital 
environment
● Screening and categorizing patients into cohorts
● Public health surveillance
● Antibiotic stewardship
● Following patient safety guidelines
Hand Hygiene
In the mid-19th Century, several researchers in Europe and 
the US, including Labarraque, Semmelweis, and Wendell 
Holmes, were working to prevent hospital-acquired, noso-
comial HCAIs.60,64–68 Although investigating indepen-
dently, their observations led them to develop a similar 
hypothesis, ie, that health care workers (HCWs) carried 
pathogenic microorganisms from one patient to another on 
their hands, transmitting pathogens to vulnerable patients 
who consequently developed infections.69 Over the next 
hundred years, much evidence accrued that pathogenic 
microorganisms were often transmitted through the hands 
of HCWs.65,70–76 Semmelweis is regarded as the first 
doctor to identify the importance of hand hygiene (HH) 
in combating contagious infectious diseases.77–80 Florence 
Nightingale, considered the founder of modern nursing 
practice,81 wrote that “every nurse ought to be careful to 
wash her hands very frequently during the day . . . with 
soap and soft water”82 subsequent to introducing hand-
washing and other hygiene practices in the war hospitals 
during the Crimean War (1853–1856).83–85 HH practices 
were slow to become widespread; however, until much 
later, for example, it was only during the foodborne dis-
eases outburst in the US in the 1980s that the Center for 
Disease Control and Prevention (CDC) recognized HH as 
a vital technique to stop the widespread infection.74,86–88 
Subsequently, the CDC produced and promoted guidelines 
regarding handwashing practices in hospitals, principally 
encouraging handwashing with non-antimicrobial soaps 
both before and after carrying out procedures with the 
possibility to spread pathogens, especially among high- 
risk patients, where they could rapidly cause a fatal 
outcome.86–90 Alcohol-based solutions were suggested 
only in circumstances where a wash-hand basin was not 
accessible.86,87 Another study in 1995 encouraged the use 
of antimicrobial soap or a waterless antiseptic agent for 
cleaning hands upon leaving the rooms of patients infected 
with multidrug-resistant microorganisms.90
Ensuring patient safety whilst in hospital and other 
healthcare facilities is a substantial international public 
health problem with HCAIs being the most common 
adverse events in any healthcare system in high- and low- 
income countries.35,50,91 Each year, hundreds of millions 
of hospitalized patients are affected with HCAIs, causing 
substantial morbidity, mortality, and financial losses for 
individuals, communities, and the public healthcare 
budget.92,93 HH has been identified as the most important 
single behavior change that healthcare workers can make 
for infection control, especially in relation to HCAIs.59,94 
For example, the strict practice of HH has been reported to 
reduce nosocomial infections by between 40% to 
70%.95,96 Despite this, rigorous hand washing strategies 
in hospitals have been observed to be weak, with multiple 
research studies reporting that globally, in many hospital 
wards, regular HH by healthcare workers often does not 
reach over 40%.97–102 Non-compliance with the guiding 
principles of HH is thus a global public health issue which 
requires more standardized policies, regular monitoring 
and surveillance, and additional research.102
The Joint Commission Journal on Quality and Patient 
Safety reports 24 reasons HCWs cited for their non- 
compliance with effective HH.103 Many reasons cited 
stem from a lack of education or training about the need 
for strict HH, leading to poor practice around ensuring and 
promoting HH as a key priority and a lack of understand-
ing of how to maintain personal and patient safety. For 
example, some HCWs thought that wearing sterile gloves 
meant that HH was unnecessary or that their hospital 
management’s requirements for HH were too extreme. 
This view was compounded by many hospitals lacking 
data and evidence about the impact of HH on infection 
rates. The high workload was cited as a key factor, with 
HCWs feeling overworked and burnt out and reporting 
a perceived lack of time to wash their hands properly or 
change their gloves between rooms/patients. HCWs also 
felt that in some clinical situations, such as emergency 
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situations, HH could not be carried out properly, and 
specific issues were reported relating to gloving and gown-
ing in isolation areas. Logistics and room design were 
reported as impacting non-compliance, for example, an 
inappropriate or troublesome location of a hand rub slot 
machine or basin; broken hand washing facilities, includ-
ing lack of hand rub or cleanser or that the supplied 
cleansing agent caused irritation or allergy. The movement 
of colleagues and relatives between rooms, sharing of 
equipment, and lack of places to work or put equipment 
and paperwork were also cited as logistical problems lead-
ing to non-compliance with routine hand washing to stop 
the spread of cross-infection.103
Stemming from this study, the Joint Commission pro-
posed five essential plans for improving HH, using the 
acronym ‘HANDS’: H = “Habit,” A = “Active feedback,” 
N = “No One Excused,” D = “Data-driven,” S = 
“Systems.”104 This plan aims to engender good HH habits 
in HCWs so that they wash their hands and maintain HH 
as an automatic behavior “upon entering or leaving 
a patient care area, as well as before and after patient 
care.” Active feedback requires health professional leaders 
to continually remind their staff about HH importance and 
adherence. Health managers and administrative staff 
should provide an appraisal of and feedback on HCWs’ 
HH practice with real-time performance data. Hospital 
authorities should regularly arrange necessary training 
programs and must acknowledge and reward hospital 
staff for achieving the targets. No one excused means 
that from the most senior to the most junior of all hospital 
staff, all are similarly accountable and responsible for 
appropriate HH hygiene. Hospital authorities should 
recognize HH as of paramount importance in maintaining 
patient care and safety, and every staff member must 
follow HH guidelines. Data-driven HH policy requires 
strict and routine monitoring and recording of compliance, 
with the data, gathered being analyzed to identify and 
prioritize areas for development and enhancement. 
Additionally, research should be continued to develop 
new ideas to resolve issues in implementing the best HH 
practice. Systems mean that HH responsiveness is 
a system-wide effort with rules and regulations regarding 
HH being applied throughout the health system. 
Authorities must provide all necessary logistic support to 
enable all workers to utilize, adhere to, and promote 
appropriate HH practice. This includes ensuring staff 
have easy access to HH facilities and using technologies 
to remind all workers to practice proper HH, emphasizing 
the benefits not only for patients but also for HCWs 
themselves.104
One recent systematic review comprising 14 articles 
concluded that a range of strategic methods is needed to 
raise HCWs’ compliance regarding HH to an adequate 
level, but implementing all these might not be 
possible.105 The interventions suggested included educa-
tional programs, monitoring, and feedback, ensuring logis-
tics support, improving access to HH agents, and 
administrative support.105 Another systematic review con-
cluded that electronic and video monitoring systems could 
be very effective in enhancing HH practice and preventing 
or controlling HCAIs.106 However, such methods are 
costly and may not be affordable for many hospitals, 
especially in low- and middle-income countries (LMICs). 
Besides, health professionals might not welcome such 
round the clock monitoring of their practice, and this 
could lead to strained professional relationships.106
In 2005, the WHO and World Alliance for Patient 
Safety started a movement, the First Global Patient 
Safety Challenge – “Clean Care is Safer Care” – aimed 
at improving HH in the healthcare system.107 This cam-
paign, known as WHO-5, encourages a multimodal plan 
comprising five different elements: “system change, train-
ing and education, observation and feedback, reminders in 
the hospital, and a hospital safety climate.”108 Currently, 
further strategies have been added based on behavioral 
sciences.108 A systematic review and meta-analysis found 
that using the WHO-5 approach improved adherence to 
HH guidance among HCWs.108 This study also suggests 
that hospital authorities should clearly set out their desired 
targets, those HCWs who meet the targets should be 
rewarded with financial incentives, and all HCWs, what-
ever their position, must be accountable. Such strategies 
lead to further improvements in HH practice. The study 
found that the resources and infrastructure required to 
report on the impact of intervention programs were often 
insufficient.108 Another systematic review found that inter-
ventions to improve HH practice based on “knowledge, 
awareness, action control, and facilitation are not enough 
to change” HH practices.109 This research additionally 
concluded that interventions should be combining diverse, 
innovative, creative strategies such as “social influence, 
attitude, self-efficacy, or intention” led to improvements. 
At present, most policy and planning aimed to ensure 
better compliance with HH guidance is targeted primarily 
at the individual and the institutional level, and “group- or 
team-directed” strategies are hardly ever used.109 This 
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research suggests that the inclusion of team-directed meth-
ods to improve HH would be more effective. This review 
concluded that more comprehensively designed planning 
is required that acknowledges the many challenges and 
barriers involved in changing HH practice and that this 
should address all levels: individual professional, team, 
and organization.109
Nurses are among the healthcare professionals who spend 
the most time on patient care and contact.110 A systematic 
review and meta-analysis evaluating HH practice among 
nurses comprised six studies: three randomized controlled 
trials, one controlled before and after study, and two inter-
rupted times series.110 This report reflects the findings from 
other studies (e.g.,),107 concluding that, whilst individual and 
collective intervention strategies could improve HH behavior 
among nurses, more impact was achieved when multimodal 
plans and policies were implemented.110 This study also 
suggests setting targets, providing rewards such as bonuses, 
benefits or financial incentives, and supporting HCWs’ indi-
vidual accountability regardless of their administrative 
position.108,110 Another systematic review comprising nine-
teen articles regarding HH knowledge and compliance 
among student nurses found a low level of knowledge and 
practice, with personal and administrative issues often influ-
encing their HH knowledge and practice.111 In summary, 
noncompliance with HH practice is a global public health 
issue that promotes more HCAIs, requiring more standar-
dized multi-modal policies and the implementation of more 
research and monitoring.102
COVID-19 and Hand Hygiene
Handwashing has regained substantial importance in the 
current global COVID-19 pandemic.112,113 Whilst a very 
simple procedure, it is one of the most important protections 
against the transmission of disease-producing 
pathogens.95,97,114,115 The CDC advises the public and 
health professionals to regularly wash their hands with 
ordinary soap and water for at least 20 seconds as it is 
considered the first-line preventive strategy of COVID-19 
contamination. Alcohol-based hand sanitizers are recom-
mended when soap and water are not accessible.116,117 
Multiple current research studies report that simple hand-
washing has prevented countless people and healthcare 
workers around the globe from acquiring COVID-19.118–124
Environmental Hygiene
Maintaining strict environmental hygiene is an essential 
component of preventing and controlling infections, 
especially in HCAIs.125,126 Infected and polluted hospital 
surfaces act as a key reservoir and source of transmission 
of life-threatening microorganisms, which include 
Clostridium difficile, antibiotic-resistant organisms such as 
methicillin-resistant Staphylococcus aureus (MRSA), and 
vancomycin-resistant enterococci (VRE).127–129 Hospital 
surfaces, including both porous surfaces, eg, beds, mattresses 
and linen, and nonporous surfaces, eg, bed rails, door han-
dles, call bells, and light switches are incredibly prone to 
microbial contamination with high-risk microbes.126,130,131 
Maintaining strict hygiene throughout hospitals is, therefore, 
essential in reducing HCAIs.126,132,133 The aim of such envir-
onmental hygiene is to minimize the number of contagious 
microorganisms that commonly exist on surfaces, as the 
reduction of pathogens reduces the possibility of the transfer 
of infectious germs from object to person, thus reducing 
cross-infection.134,135 Hospital cleaning is a complex and 
multi-layered process which involves the physical removal 
(utilizing detergents, chemical disinfectants, and water) of 
contagious and infectious material from all types of surface, 
including sputum, urine, blood, secretions, excretions, micro-
organisms and dust, that can nourish the growth of 
microorganisms.136–141
The US Center for Disease Control and Prevention 
(CDC) and the Healthcare Infection Control Practices 
Advisory Committee endorses that infection prevention and 
control is the most urgent and vital issue wherever medical 
care is provided to individuals or communities, irrespective 
of the type or size of the organization and the healthcare 
provided.142,143 Appropriate safety measures should include 
a routine, deep cleaning of all areas of the hospital, both in- 
patient and out-patient, to minimize communicable transmis-
sion infectious diseases.142,143 Antimicrobials used for hos-
pital cleaning comprise both single or multiple components 
aimed to extinguish or arrest the growth of infectious disease- 
producing microorganisms, including bacteria, viruses, or 
fungi. Hospital cleansing products may contain about 275 
different constituents and are available in various formula-
tions such as sprays, liquids, concentrated powders, and 
gases.144 It is crucial for users to understand the level and 
type of cleaning, its purpose, and limitations, including the 
various terms, definitions, and classification used (eg, ster-
ilization, disinfection, cleaning) and the categorization of 
devices and surfaces that require specific measures.145,146 
Ethylene oxide gas is used for sterilization, which aims to 
kill all microorganisms.146–148 Disinfection can eliminate 
nearly all metabolically active microorganisms except for 
all microbial spores149 Hydrogen peroxide (7.5%) is 
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a common agent utilized for high-level disinfection.86,87,146 
Isopropyl alcohols with a concentration of 70–90% can pro-
vide intermediate-level disinfection by the eradication of all 
vegetative microorganisms with a small number of bacterial 
spores.146 A quaternary ammonium microbial detergent solu-
tion can achieve low-level disinfection by eradicating most 
metabolically active bacteria, some fungi, and viruses but not 
metabolically inactive spores.86,146 Cleaning is described as 
the removal of soil, dust, earth, or biological pollution from 
an instrument or hospital physical surface through brushing, 
scrubbing or scraping, using detergent, the surfactant or 
emulsifying agents that reduce surface tension, and water. 
Cleaning eliminates many contagious microbes from hospital 
surfaces, thereby reducing the bacterial load on surfaces. 
Cleaning is, therefore, the first stage of maintaining hospital 
hygiene, particularly for surfaces having evident pollution, 
and helps to safeguard the success of subsequent disinfection 
procedures.145
Screening and Cohorting Patients
There is increasing political and community concern 
because multiple approaches have failed or struggled to 
control the spread of HCAIs, resulting in high morbidity 
and mortality due to AMR infections developed during 
hospital stays.150–155 Strategies aimed at minimizing and 
controlling HCAIs comprise active surveillance cultures 
(ASCs), contact isolation of patients colonized with epi-
demiologically significant pathogens, and pre-emptive iso-
lation of high-risk patients.156
It has been suggested that ASCs of all or certain high- 
risk patients and placing them under contact precautions 
will help to curb or eliminate the multidrug-resistant 
organisms (MDROs) that can trigger HCAIs.157 
Implementing ASCs is not straightforward, however, rais-
ing ethical issues around conflict of interests and confiden-
tiality, practical issues around logistics and bed 
management, which may lead to isolating or segregating 
patients when they did not need to be, reallocation of 
budgets to manage the potentially infected patients, and 
reduction of healthcare output. ASCs can particularly 
affect workload in emergency rooms and the ambulance 
service. Considering these issues, some researchers con-
cluded that implementing ASCs needs to be based on 
accurate assessments of the impact on public health, and 
the costs and benefits in relation to existing prevention and 
control measures.158 A systematic review comprising 
twenty articles found that although ASCs have been 
recommended for different hospitals to control the 
increasing numbers of infections due to multidrug- 
resistant organisms, their effectiveness and cost- 
effectiveness are not proven.159 Another prospective 
study identified that ASCs conducted on patients admitted 
to ICU did not find the microbes causing bacteriological 
diseases with the most severe consequences and that 
bloodstream infections might not, therefore, be associated 
with ASCs.160 Again, in the ICU setting, a study carried 
out for four years found that management of MRSA in the 
ICU does not require ASCs.161
Several countries have successfully reduced the inten-
sities of MRSA infections by executing countrywide con-
trolling strategies such as “search and destroy” (S&D).162 
Measures of S&D include the segregation of MRSA- 
positive patients; anticipatory separation and assessment 
and evaluation of high-risk cases; screening of patients and 
staff after an unexpected case of MRSA; assessment of 
HCWs who are on leave as potential carriers; total decon-
tamination where required and stopping new admissions in 
areas where more than one carrier found amongst hospita-
lized patients.163 MDR pathogens such as MRSA, VRE, 
and multidrug-resistant Gram-negative bacilli (MDR- 
GNB) are often found in many hospitals and healthcare 
settings and act as a potential source of MDR 
outbreaks.164–166 One earlier study reported that 
approaches to the transmission of HCAIs “include contact 
isolation, cohorting care, maintaining appropriate staffing 
ratios, use of active microbiologic surveillance, and 
decreasing hospital stays.”163 Multiple studies suggested 
that patient isolation, ASCs, and staff screening can 
decrease the transmission of MDR pathogens.164,167 And 
finally, another study found that the anticipatory use of 
sterile “gloves, with or without a gown,” especially among 
patients with a high risk of carrying contagious diseases, 
were very effective in the management of an outbreak of 
MDRs.168
Surveillance
Public health surveillance is defined as the ongoing sys-
tematic collection, analysis, interpretation, and dissemina-
tion of data regarding a health-related event for use in 
public health action to reduce morbidity and mortality 
and to improve health.169 Surveillance data regarding 
HCAIs can be used to assess the extent, escalation, and 
status of infections, to examine, scan and monitor trends of 
infection rates, inform alert programs, and improve per-
formances, strategy and competence development.170,171 
One Scottish study suggested that because the surveillance 
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system in Scotland was not so well-organized, the time 
taken to first recognize HCAIs was longer than the gold 
standard.172 This study also found that the time at which 
HCAIs are recognized can be reduced either by “increas-
ing the number of hospitals participating in surveillance or 
by optimally selecting which hospitals to include in 
a surveillance system.”172 Two other Scottish studies 
echoed this, reporting that a better surveillance system 
could have prevented a considerable number of 
Staphylococcus aureus bacteremia (SAB) episodes.173,174 
One recent Indian observational prospective study noted 
a low incidence of HCAIs due to the strict practice of 
active surveillance in a neurosurgery unit.175 In Germany, 
the Krankenhaus Infections Surveillance System (KISS) 
was found to decrease HCAIs more efficiently in compar-
ison to other protocols.176 This system is like that 
described by the CDC and is structured like the National 
Nosocomial Surveillance system of the USA.177,178 
However, another German study reported that the KISS 
surveillance system tended to miscalculate the rates of 
HCAIs.179 Later, yet another German study reported that 
around 35% of ICUs in Germany have never isolated 
patients with MRSA as individuals or cohorts.180 
Isolation of MDRs infected patients is one of the top 
priority issues in preventing or controlling an HCAIs 
epidemic.140,181,182 The timely recognition of the unique 
variants of HCAIs, especially of MDRs pathogenic micro-
organisms, is vital, although surveillance strategies are 
frequently restricted because of financial and practical 
limitations. Therefore, although surveillance is extensively 
acknowledged as playing an active part in preventing and 
controlling HCAIs, there is not enough evidence on how 
well-organized individual healthcare centered surveillance 
structures work and how lessons can be applied in low 
resource settings.183
Antibiotic Stewardship
The term Antimicrobial Stewardship (AS) was first coined 
by McGowan and Gerding in 1996.184 They highlighted 
that physicians and other health professionals must see 
antimicrobials as a very valuable one-time healthcare 
resource.183 The Society for Healthcare Epidemiology of 
America defines Antibiotic Stewardship as a set of coor-
dinated strategies to improve the use of antimicrobial 
medications with the goal of enhancing patient health out-
comes, reducing resistance to antibiotics, and decreasing 
unnecessary costs.185 AS is also described as the optimal 
selection, dosage, and duration of antimicrobial treatment 
that results in the best clinical outcome for the treatment or 
prevention of infection, with minimal toxicity to the 
patient and minimal impact on subsequent resistance.186 
As promotes the prudent and rational use of antimicrobials 
and helps avoid excessively or in appropriate use.187
Hey, surgeons! It is time to lead and be a champion in 
preventing and managing surgical infections!188 
The World Society of Emergency Surgery (WSES) states 
that surgeons should take the lead in infection prevention, 
policy, planning, and implementation. WSES has devel-
oped several guidelines for infection prevention, particu-
larly for surgery-related issues, aimed at improving health 
outcomes in relation to surgical infection-related 
management.188–191 Scientists at Tufts Medical Center 
suggest that whilst AMR is increasing globally, the devel-
opment of new antibiotics has slowed, and therefore, the 
conservation of antimicrobials is essential.192 The CDC 
describes the seven core elements of AS as “leadership 
commitment, accountability, drug expertise, action, track-
ing, reporting, and education.”193 The three primary objec-
tives of AS are first, to ensure prudent and rational 
utilization of antimicrobials with precisely targeted doses 
of the right antibiotic, the “de-escalation to pathogen- 
directed therapy,” and to deliver antibiotic therapy to an 
agreed, precise timeframe.192,194 The second objective is 
the need to halt overall antimicrobial overuse, misuse, and 
abuse in both community and in-patient hospital facilities, 
and the third are to halt or slow the expansion of 
resistance.192
The two most important methods of approach to AS are 
described, with the most effective initiatives combining both 
approaches.192 The first method of stewardship is in restrain-
ing “prescriptive authority.” Clinicians should be restricted 
from prescribing specific antimicrobials, and they should be 
required to seek prior approval for prescribing such 
antimicrobials.192 The second method bases treatment on 
laboratory reports of culture sensitivity tests, not just clinical 
signs and symptoms, to ensure that the antibiotic prescribed (if 
any) is appropriate. Only then should these antibiotics be made 
available to physicians with guidance that antibiotic availabil-
ity and treatment might be adjusted, or even suspended.192 
Multiple research studies report that the combination of these 
approaches reduced antimicrobial prescribing and led to 
higher satisfaction about the quality of care in both doctors 
and patients.195,196 A systematic review and meta-analysis 
recently reported that AS initiatives have specifically 
decreased the frequency of infectious diseases and 
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“colonization with antibiotic-resistant bacteria and 
Clostridium difficile infections in hospital inpatients.”197 
These reports provide healthcare professionals and policy-
makers “with evidence for the implementation of antibiotic 
stewardship interventions to reduce the burden of infections 
from antibiotic-resistant bacteria.”197 One prospective apprai-
sal of 176 ASP interventions reported a significantly reduced 
antimicrobial use of 24.3%. It concluded that this had a very 
positive impact on overall antimicrobial usage, length of ther-
apy, and length of in-hospital stay.198 One quasi-experimental 
retrospective analysis found that the introduction of ASP was 
associated with a decrease in antibiotic use as well as overall 
healthcare costs, with a significant reduction in the incidence 
of some microbes.199 Another systematic review showed that 
the implementation of hospital ASPs made significant 
improvements in infection rates and clinical outcomes as 
well as financial savings.200 Furthermore, another systematic 
review and meta-analysis found that ASPs in hospitalized 
patients in the Asia Pacific region effectively reduced antimi-
crobial use, and improved patient’s treatment outcomes.201 
One additional study reported that improved ASP is essential 
to stop or limit the emergence of AMR, lengthen the efficacy 
of available antimicrobials, provide better healthcare out-
comes and reduce the healthcare costs of HCAIs for both 
individuals and communities.202 Another study described 
three different strategies to control antimicrobial resistance: 
infection prevention and control, diagnostic stewardship, and 
antimicrobial stewardship.203
Following Patient Safety Guidelines
Policies, guidelines, and checklists are an essential part of 
improving patient safety; however, these are often inter-
preted and implemented differently by individuals, depart-
ments, and organizations, based on local influences and 
practices and often not taken behavioral science into 
account.204–206 A study investigating the failure of an 
HCAIs strategy found low levels of physician engagement 
and compliance with guidelines and policies.207,208 Even 
in healthcare facilities where policies, guidelines, and 
checklists were effectively implemented, doctors and 
other health professionals’ practices were found to degrade 
after around one year. The reasons given included: too 
much information being provided; guidelines being too 
complicated to implement; that guidelines conflicted with 
other guidelines, and because little evidence was provided 
to support the guidance.209,210
All healthcare policies and planning around patient 
safety must embed the prevention and control of HCAIs 
as a fundamental principle.36,206,211,212 As mentioned ear-
lier, the control and prevention of HCAIs is best achieved 
through a broad, integrated approach and cooperation 
between healthcare facilities, public health authorities, 
health insurances, quality management, and patient safety 
organizations, educational facilities, the public, and the 
veterinarian sector.213 Another study regarding the 
improvement of patient safety identified that the following 
measures helped to optimize the impact of a program: 
ensure that the educational program is introduced well and 
certified; report the program outcomes publicly; carefully 
design healthcare settings with patient safety in mind; pro-
mote an informed and transparent managerial approach; 
provide clear guidance and role modeling; facilitate colla-
boration between the healthcare program and government 
health institution; reduce hospital overcapacity; ensure 
accountability, and provide financial support.214
Strategies for the Prevention of 
COVID-19
In order to combat the COVID-19 crisis, health systems 
leaders around the world have had to adopt rapid multiple 
lines of attack to appraise critical requirements and address 
areas of weakness.215 This includes taking a rigorous 
approach to reduce the rates of COVID-19 infection, hos-
pitalization, morbidity, and mortality.216,217 The appropri-
ate strategy for preparedness to face COVID-19 or any 
future pandemic must be based on reputable guidelines, 
protocols, and direct experiences of those working on the 
front line during the COVID-19 pandemic.216,218 The 
foundations of an operational COVID-19 preventive vigi-
lance and action plan include: 1) mitigating local transmis-
sion; 2) conserving, supporting, and protecting staff; 3) 
eliminating non-urgent strains on the system and 4) coor-
dinating communication.216 Because hospitals and clinics 
are considered as core areas for the transmission of 
COVID-19,219 three principal measures should be imple-
mented to reduce preventable exposure and transmission 
of COVID-19: 1) restrict both visitors and other non- 
COVID-19 patients to the health care facility; 2) specific 
healthcare workers need to work in the COVID-19 zone; 
and 3) every person must be screened and tested regularly 
before and after entering the hospital facility.216,219,220
Limitations of the Study
This is a narrative review and not a systematic review, so it 
is not all-inclusive. Plus, the topic of strategies to prevent 
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HCAIs is extremely broad, and therefore it has not been 
possible to include all discussions relating to the preven-
tion and control of HCAIs in a single manuscript; there-
fore, the authors have focused on identifying the most 
significant features of the current debate.
Conclusions
HCAIs are an increasingly important and severe public health 
issue about which concerns have been expressed among all 
stakeholders involved in healthcare, including doctors, nurses, 
allied health professionals, patients, and the public.45–48,221 
Globally, the prevention and control of HCAIs have become 
an urgent issue, particularly because of the rise of multidrug- 
resistant pathogenic microorganisms.49–51 This research study 
found overwhelmingly that hand and environmental hygiene 
with antibiotic stewardship are the principal measures that 
minimize HCAIs and improve treatment outcomes.
Recommendations
Determined actions are required to address the burden of 
healthcare-associated infections worldwide and improve 
patient safety. Hand hygiene and the prudent use of antimi-
crobials are the key strategies in preventing HCAIs. Hand 
hygiene is the leading measure for preventing the spread of 
antimicrobial resistance and reducing HCAIs. Hand hygiene 
can prevent a significant number of HCAIs since healthcare 
workers’ hands are the most common vehicle for the trans-
mission of healthcare-associated pathogens from patient to 
patient and within the healthcare environment. Available 
evidence highlights the fact that multimodal intervention 
strategies lead to improved hand hygiene and a reduction in 
HCAIs. The introduction of alcohol-based hand rubs and 
continuous educational programs are key factors to over-
come infrastructure barriers and to build robust knowledge 
improvement. Antimicrobial stewardship is also vital to opti-
mize the use of antimicrobials to prevent the development of 
resistance and improve patient outcomes. Coordinated stra-
tegies are required between all actors in the system to help 
prevent antimicrobial resistance.
Key Findings
● HCAIs are the leading cause of morbidity and mor-
tality worldwide, and most of them are preventable.
● Hand hygiene is the most effective, simplest, and 
cheapest measure to prevent HCAIs, but compliance 
with hand hygiene remains low amongst HCWs.
● In order to improve hand hygiene compliance among 
HCWs, intervention strategies should be implemented, 
and standardized measures for monitoring should be 
put in place.
● Ensuring adequate hospital environmental hygiene is 
essential for reducing the threat of HCAIs by mini-
mizing the number of contagious microorganisms 
existing on surfaces and reducing cross-infection.
● The cost-effectiveness of active surveillance cultures 
(ASCs) is not proven. Contact isolation of patients 
colonized or infected by pathogens can decrease the 
transmission of drug-resistant organisms.
● Active and passive surveillance programs should be 
implemented to assess and monitor the extent and 
trends of HCAIs, to develop precautionary programs, 
and improve performance, strategy, and competence 
development.
● The implementation of Antibiotic Stewardship 
Programs is vital to enhance patient health outcomes, 
reduce resistance to antibiotics, and decrease unne-
cessary costs.
● Guidelines are an important tool to improve patient 
safety, and efforts should be put into action to 
improve HCWs adherence to them.
● Extensive integrated approaches involving coopera-
tion between public health authorities and HCWs are 
needed to maximize patient safety by preventing 
HCAIs.
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